|
|
|
|
| LEADER |
01230nam a2200229 a 4500 |
| 001 |
1781005 |
| 005 |
20171111234528.0 |
| 008 |
091001s2010 nyua sb 001 0 eng d |
| 020 |
|
|
|z 9781607419617 (hardcover : alk. paper)
|z 1607419610 (hardcover : alk. paper)
|
| 040 |
|
|
|a CaPaEBR
|z 9781614704386 (e-book)
|
| 050 |
1 |
4 |
|a RM671.5.U6
|b N66 2010eb
|
| 245 |
0 |
0 |
|a Nonprescription drugs
|b considering a new class for behind-the-counter drugs /
|c Lars P. Eliassen, editor.
|
| 260 |
|
|
|a New York :
|b Nova Science Publishers,
|c c2010.
|
| 300 |
|
|
|a viii, 199 p. :
|b ill.
|
| 490 |
1 |
|
|a Pharmacology-research, safety testing and regulation series
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Nonprescription drugs : considerations regarding a behind-the-counter drug class / Government Accountability Office -- Food and Drug Administration behind the counter availability of certain drugs, public meeting / United States Department of Health and Human Services.
|
| 650 |
|
0 |
|a Drugs, Nonprescription
|x Government policy
|z United States.
|
| 700 |
1 |
|
|a Eliassen, Lars P.
|
| 710 |
2 |
|
|a ebrary, Inc.
|
| 856 |
4 |
0 |
|u http://site.ebrary.com/lib/ucy/Doc?id=10677961
|
| 952 |
|
|
|a CY-NiOUC
|b 5a0456c26c5ad14ac1ece23c
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
